Secukinumab Shows Sustained Efficacy in Difficult-to-Treat Palmoplantar, Nail, and Scalp Psoriasis: Long-Term Results from Three Phase III Placebo-Controlled Randomized Trials

Authors

Kristian Reich
Alice B. Gottlieb, New York Medical CollegeFollow
Mark Lebwohl
Renata Kisa
Jennifer Frueh

Author Type(s)

Faculty

Document Type

Abstract

Publication Date

9-2018

Journal Title

Journal of the American Academy of Dermatology

Department

Dermatology

Recommended Citation

Reich, K., Gottlieb, A. B., Lebwohl, M., Kisa, R., & Frueh, J. (2018). Secukinumab Shows Sustained Efficacy in Difficult-to-Treat Palmoplantar, Nail, and Scalp Psoriasis: Long-Term Results from Three Phase III Placebo-Controlled Randomized Trials. Journal of the American Academy of Dermatology, 79 (3 Suppl.1), AB257. Retrieved from https://touroscholar.touro.edu/nymc_fac_abstracts/348